Company intelligence / Profile preview

Avicenna.AI

La Ciotat, Provence-Alpes-Côte d'Azur, Franceavicenna.ai ↗

Ownership: Private
Development stage: Commercial

Overview

Avicenna.AI’s deep learning-powered software solutions are commercially available and used to expedite detection of life-threatening pathologies from CT scans. The company has raised over $10 million in funding to expand its global deployment and diversify into new medical areas. Its tools are designed to reduce interpretation time for emergency cases and optimize patient management workflows in radiology departments

Therapeutic areas: OtherCardiovascular
Modalities: DeviceSoftware (AI-based diagnostic support)
Industry: Medical Imaging

Beyond the preview

Go deeper on Avicenna.AI.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Avicenna.AI.

Explore the full profile